Abstract
Prosurfactant protein B (pro-SFTPB) and surfactant protein D (SFTPD) are markers of lung inflammation and damage. We estimated geometric mean pro-SFTPB and SFTPD levels in 500 human immunodeficiency virus (HIV)-infected and 300 HIV-uninfected injection drug users, adjusting for smoking and other covariates. Pro-SFTPB levels were significantly higher among people with HIV (PWH) (adjusted geometric mean, 21.4 vs 18.1 ng/mL; P = .03), and were higher with lower CD4 counts (P trend = .001), higher HIV RNA (P trend = .05), and without highly active antiretroviral therapy (P = .03). These associations were not observed for SFTPD. Serum levels of pro-SFTPB are elevated among PWH and are associated with immunosuppression and uncontrolled viremia.
Author supplied keywords
Cite
CITATION STYLE
Shiels, M. S., Kirk, G. D., Drummond, M. B., Dhillon, D., Hanash, S. M., Taguchi, A., & Engels, E. A. (2018). HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D. In Journal of Infectious Diseases (Vol. 217, pp. 413–417). Oxford University Press. https://doi.org/10.1093/infdis/jix510
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.